Search

everythinglearnresearchcommunity

for

Search:↓

Topical GT20029 effectively promotes hair regrowth and is well-tolerated for treating androgenetic alopecia.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

AMP-303 safely increases hair growth in men with hair loss.

Clascoterone is safe for the heart, even at high doses.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Retinoids may help treat lupus nephritis and reduce steroid use.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

The treatment with valproate, acetylcarnitine, folic acid, and vitamin B12 may improve muscle strength in children with SMA without significant side effects.

Baricitinib is effective and safe for treating severe alopecia areata.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

The goal is to create a tool for patients to report their experiences with various hair and scalp disorders.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated.